COO's premium lens, myopia control and fertility momentum support growth, but Asia-Pacific weakness and margin pressure keep ...

COO's MyDay, MiSight and fertility strengths support the long-term case, but Asia-Pacific softness, recall costs and leverage ...

COO sits at the intersection of two durable healthcare trends: premium vision care and fertility demand. Its CooperVision ...

Contact lenses are safe and effective, but wearing them during some activities can increase the risk of rare but serious ...

According to the latest market analysis by Future Market Insights, the global therapeutic contact lenses market is growing rapidly as medically prescribed ...

ROCHESTER, N.Y., April 9, 2026 /PRNewswire/ -- CooperVision announced today the launch of its MADE BETTER™ Promise—a new global sustainability platform focused on smarter, more sustainable choices.*†1 ...

Dr. Yangzhi Zhu from the Terasaki Institute for Biomedical Innovation has published a research paper titled "Real-time intraocular pressure monitoring and responsive drug delivery in preclinical ...

Shanghai Moody Technology Co. is considering a sale that could value the colored contact lens maker at about $1 billion, people familiar with the matter said. The company is working with an adviser ...

Second Phase of Rollout Builds on Strong Momentum Across Europe and UK. The expansions underscore the company's commitment to making evidence-based myopia management interventions accessible to eye ...

MiSight ® 1 day is the first soft contact lens authorized by Japan's Ministry of Health, Labor and Welfare for use by children to correct myopia and control its progression. †‡3 "This milestone ...

CEVA Logistics, in collaboration with CooperVision Asia Pacific, has opened a new regional service centre in Singapore. Located in CEVA’s healthcare hub facility within Singapore’s Airport Logistics ...